ASCVD Clinical Trial - High-intensity Rosuvastatin & Moderate-intensity

Updated 06/21/2024

Status Completed

Clinical Trial Summary

This study will evaluate the efficacy and safety of high-intensity rosuvastatin and moderate-intensity rosuvastatin/ezetimibe in ASCVD patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

ASCVD

Clinical Trial Details

NCT number	NCT03494270
Study type	Interventional
Source	Yuhan Corporation
Contact
Status	Completed
Phase	Phase 4
Start date	March 18, 2018
Completion date	September 26, 2019

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05390892` - PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes	Phase 4
	Active, not recruiting	`NCT05088759` - Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management	N/A
	Not yet recruiting	`NCT04093440` - Cardiometabolic Syndrome Response to Therapeutic Lifestyle Changes	N/A
	Recruiting	`NCT05611307` - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
	Completed	`NCT03400800` - Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol	Phase 3
	Not yet recruiting	`NCT06404515` - Telehealth Group Counseling and Preventive Care for Women	N/A
	Recruiting	`NCT03606824` - Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)	N/A
	Recruiting	`NCT05579626` - Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)	N/A
	Recruiting	`NCT06005597` - Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies	Phase 3
	Not yet recruiting	`NCT05858879` - Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)	N/A
	Active, not recruiting	`NCT06295861` - Prospective Cohort Study of Panvascular Disease
	Terminated	`NCT04197453` - The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)
	Completed	`NCT03399370` - Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol	Phase 3
	Not yet recruiting	`NCT05976893` - Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer	Phase 4
	Completed	`NCT03474562` - High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension	Phase 4
	Completed	`NCT03814187` - Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C	Phase 3